Keywords: QRxPharma, MoxDuo, USA, FDA, PDUFA date, Acute pain, Prescription opioids

US FDA sets PDUFA date for QRxPharma's resubmitted MoxDuo NDA

Article | 15 March 2013

Print This

Australia-based QRxPharma (ASX: QRX) says that the US Food and Drug Administration has set August 26, 2013, as the Prescription Drug User ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in